Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Ovarian cancer
Closed
Phase 2
This trial is looking at TAK228 to treat ovarian cancer that has continued to grow or come back after chemotherapy.
It is for women who have:
Treatment for these cancers is the same, so when we use the term ovarian cancer in this summary, we are referring to all 3.
Recruitment start: 4 September 2018
Recruitment end: 12 July 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Jonathan Krell
Imperial College London
Takeda Pharmaceuticals International, Inc.
North Eastern Germany Society of Gynaecologic Oncology
Last reviewed: 4 October 2021
CRUK internal database number: 16421
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
